Ligand Pharmaceuticals Incorporated (LGND)

NASDAQ: LGND · IEX Real-Time Price · USD

99.76

+0.80 (0.81%)

At close: Jul 19, 2024, 4:00 PM

99.77

+0.01 (0.01%)

Pre-market: Jul 20, 2024, 9:29 AM EDT

Ligand Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 1994
Revenue	118.31	131.31	196.25	241.54	163.56	120.28	Upgrade
Revenue Growth (YoY)	-41.92%	-33.09%	-18.75%	47.68%	35.98%	-52.17%	Upgrade
Cost of Revenue	9.68	10.51	52.83	62.18	30.42	11.35	Upgrade
Gross Profit	108.64	120.8	143.42	179.37	133.14	108.94	Upgrade
Selling, General & Admin	52.89	52.79	70.06	46.79	60.01	41.88	Upgrade
Research & Development	23.85	24.54	36.08	32.11	40.5	55.91	Upgrade
Other Operating Expenses	31.18	31.53	34.24	-3.38	-4.87	-795.93	Upgrade
Operating Expenses	107.91	108.86	140.38	75.52	95.64	-698.14	Upgrade
Operating Income	0.73	11.94	3.04	103.85	37.5	807.08	Upgrade
Interest Expense / Income	0.56	0.66	1.8	19.62	27.42	35.75	Upgrade
Other Expense / Income	-121.4	-50.71	-6.63	31.24	18.38	-25.31	Upgrade
Pretax Income	121.57	62	7.87	52.99	-8.29	796.64	Upgrade
Income Tax	25.23	9.84	41.23	-4.15	-5.31	167.34	Upgrade
Net Income	96.34	52.15	-33.36	57.14	-2.99	629.3	Upgrade
Net Income Growth	301.89%	-	-	-	-	339.09%	Upgrade
Shares Outstanding (Basic)	18	17	17	17	16	19	Upgrade
Shares Outstanding (Diluted)	18	18	17	17	17	20	Upgrade
Shares Change	0.82%	5.27%	-2.19%	2.50%	-14.84%	-17.91%	Upgrade
EPS (Basic)	5.45	3.02	-1.98	3.44	-0.18	33.13	Upgrade
EPS (Diluted)	5.32	2.94	-1.98	3.31	-0.18	31.85	Upgrade
EPS Growth	325.60%	-	-	-	-	434.40%	Upgrade
Free Cash Flow	-16.89	-3.85	120.02	70.53	51.49	-31.89	Upgrade
Free Cash Flow Per Share	-0.95	-0.22	7.12	4.24	3.18	-1.68	Upgrade
Gross Margin	91.82%	91.99%	73.08%	74.26%	81.40%	90.57%	Upgrade
Operating Margin	0.61%	9.09%	1.55%	42.99%	22.93%	670.99%	Upgrade
Profit Margin	81.43%	39.72%	-17.00%	23.66%	-1.82%	523.19%	Upgrade
Free Cash Flow Margin	-14.28%	-2.93%	61.16%	29.20%	31.48%	-26.51%	Upgrade
Effective Tax Rate	20.75%	15.87%	523.95%	-7.83%	-	21.01%	Upgrade
EBITDA	158.8	100.03	66.56	128.4	48.7	876.12	Upgrade
EBITDA Margin	134.22%	76.18%	33.92%	53.16%	29.77%	728.38%	Upgrade
Depreciation & Amortization	36.68	37.38	56.89	55.79	29.58	43.73	Upgrade
EBIT	122.13	62.65	9.67	72.61	19.12	832.38	Upgrade
EBIT Margin	103.22%	47.71%	4.93%	30.06%	11.69%	692.03%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).